The Valley Desk

ReviewClinical and translational allergyPublished

GA2LEN ANACARE consensus statement: Potential of omalizumab in food allergy management

12 of 56 authors shown in byline order.

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Review
Venue
Clinical and translational allergy
Published
Subject terms
Desensitization; Immunoglobulin E; Food allergy; Omalizumab; anaphylaxis
PubMed ID
39506193
PubMed Central ID
PMC11540805
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal